Notice Information
Notice Title
Clean Room Requalification
Notice Description
NHS Blood and Transplant (NHSBT) have a requirement for Clean Room Requalification. The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) is a specialist facility that manufactures plasmids and viral vectors for early-stage clinical trials targeting incurable diseases like cancer and genetic disorders. Operating as part of NHSBT's Cellular and Molecular Therapies function, the CBC supports the UK life sciences sector by translating laboratory research into clinical-grade therapies. The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials. These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 "The rules governing medicinal products in the European Union" Annex 1 Manufacture of sterile medicinal products. Classification and Re-qualification is performed at a minimum annually At Rest, except for particle counts which are performed At Rest and In Operation.
Planning Information
NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held on-line via Microsoft Teams during w/c 27th July 2026. Any interested organisations are asked to contact carley.butcher@nhsbt.nhs.uk by no later than 17:00 on the 17th July 2026 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria and timescales may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-06bf4b
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/060844-2026
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- UK2 - Preliminary Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- SME
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
71 - Architectural, construction, engineering and inspection services
-
- CPV Codes
71600000 - Technical testing, analysis and consultancy services
71630000 - Technical inspection and testing services
71631000 - Technical inspection services
Notice Value(s)
- Tender Value
- £80,000 Under £100K
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 29 Jun 20262 weeks ago
- Submission Deadline
- Not specified
- Future Notice Date
- 21 Sep 20263 months to go
- Award Date
- Not specified
- Contract Period
- 2 Nov 2026 - 1 Nov 2029 3-4 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Planning
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS BLOOD AND TRANSPLANT
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- BRISTOL
- Postcode
- BS34 7QH
- Post Town
- Bristol
- Country
- England
-
- Major Region (ITL 1)
- TLK South West (England)
- Basic Region (ITL 2)
- TLK5 West of England
- Small Region (ITL 3)
- TLK52 Bath & North East Somerset and South Gloucestershire
- Delivery Location
- Not specified
-
- Local Authority
- South Gloucestershire
- Electoral Ward
- Filton
- Westminster Constituency
- Filton and Bradley Stoke
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/060844-2026
29th June 2026 - Preliminary market engagement notice on Find a Tender
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-06bf4b-2026-06-29T15:09:21+01:00",
"date": "2026-06-29T15:09:21+01:00",
"ocid": "ocds-h6vhtk-06bf4b",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PDBY-6395-VWBP",
"name": "NHS Blood and Transplant",
"identifier": {
"scheme": "GB-PPON",
"id": "PDBY-6395-VWBP"
},
"address": {
"streetAddress": "500 North Bristol Park",
"locality": "Bristol",
"postalCode": "BS34 7QH",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK12"
},
"contactPoint": {
"name": "Carley Butcher",
"email": "carley.butcher@nhsbt.nhs.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.nhsbt.nhs.uk/",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
}
}
],
"buyer": {
"id": "GB-PPON-PDBY-6395-VWBP",
"name": "NHS Blood and Transplant"
},
"planning": {
"milestones": [
{
"id": "engagement",
"type": "engagement",
"description": "NHSBT wishes to invite those organisations who express an interest in this opportunity to Supplier engagement meetings to be held on-line via Microsoft Teams during w/c 27th July 2026. Any interested organisations are asked to contact carley.butcher@nhsbt.nhs.uk by no later than 17:00 on the 17th July 2026 to express their interest. If you do not respond by this date, you are not excluded from participating in the forthcoming tender, this date is to allow for optional supplier engagement meetings to be organised. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position. Further information e.g. draft technical specification, award criteria and timescales may be released for consultation purposes only, to organisations who express an interest in this notice. Please note that all details are subject to change.",
"dueDate": "2026-07-17T23:59:59+01:00",
"status": "scheduled"
}
],
"documents": [
{
"id": "060844-2026",
"documentType": "marketEngagementNotice",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/060844-2026",
"datePublished": "2026-06-29T15:09:21+01:00",
"format": "text/html"
}
]
},
"tender": {
"id": "C455532",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "Clean Room Requalification",
"description": "NHS Blood and Transplant (NHSBT) have a requirement for Clean Room Requalification. The Clinical Biotechnology Centre (CBC) at NHS Blood and Transplant (NHSBT) is a specialist facility that manufactures plasmids and viral vectors for early-stage clinical trials targeting incurable diseases like cancer and genetic disorders. Operating as part of NHSBT's Cellular and Molecular Therapies function, the CBC supports the UK life sciences sector by translating laboratory research into clinical-grade therapies. The manufacture of sterile products or tissues should be carried out in clean areas, entry to which is through change rooms/air locks/transfer hatches for personnel/equipment and materials. These classified environments MUST be monitored and achieve the appropriate current GMP regulatory specifications for that environment as detailed in EudraLex volume 4 \"The rules governing medicinal products in the European Union\" Annex 1 Manufacture of sterile medicinal products. Classification and Re-qualification is performed at a minimum annually At Rest, except for particle counts which are performed At Rest and In Operation.",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "71630000",
"description": "Technical inspection and testing services"
},
{
"scheme": "CPV",
"id": "71631000",
"description": "Technical inspection services"
},
{
"scheme": "CPV",
"id": "71600000",
"description": "Technical testing, analysis and consultancy services"
}
],
"deliveryAddresses": [
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "1"
}
],
"value": {
"amountGross": 96000,
"amount": 80000,
"currency": "GBP"
},
"mainProcurementCategory": "services",
"aboveThreshold": false,
"lots": [
{
"id": "1",
"suitability": {
"sme": true
},
"contractPeriod": {
"startDate": "2026-11-02T00:00:00Z",
"endDate": "2029-11-01T23:59:59Z",
"maxExtentDate": "2030-11-01T23:59:59Z"
},
"hasRenewal": true,
"status": "planning"
}
],
"communication": {
"futureNoticeDate": "2026-09-21T23:59:59+01:00"
},
"status": "planning"
},
"language": "en"
}